ORTEXORTEX News
Tracking CSTM? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CS
ConfluenceCSTM

JP Morgan Upgrades CSTM as Post-Earnings Picture Clears

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 29 Oct 2026, 20:41

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Constellium SE gets a boost from Wall Street's most bullish call in months. The aluminum producer received an upgrade to Overweight from JP Morgan on October 29, even as the stock sits 4.5% lower on the week.

Why this matters: JP Morgan's move cuts against a week of analyst caution and elevated put demand after Q3. The upgrade adds a meaningful divergence to an otherwise cautious post-earnings consensus.

JP Morgan Breaks With the Pack

Bill Peterson at JP Morgan upgraded CSTM to Overweight from Neutral and raised his price target to $35 from $34. At the current price of $24.43, that implies 43% upside. It is a sharply different read from the moves filed by the rest of the desk this week. Wells Fargo's Timna Tanners maintained Overweight but cut the target to $33 from $38, a $5 reduction. UBS cut to $32 from $34 in early October. Deutsche Bank cut to $36 from $39 on the same day. Barclays initiated at Equal-Weight with a $28 target on October 14. Every other firm that moved in October moved lower. JP Morgan is the only one going the other way.

The mean target now stands at $30.04. JP Morgan's $35 sits well above that. Whether it pulls the consensus higher will depend on whether other desks follow the upgrade or hold their reduced targets into Q4.

Retail Attention Spiked Into Earnings

One supporting note from alt data: retail interest in CSTM jumped sharply around the earnings print. Wikipedia views and ORTEX page traffic combined to push a retail attention reading 3.67 standard deviations above its 90-day average as of October 28. This is an attention measure, not a revenue indicator, but the timing is notable given the post-earnings price action.

Options and Borrow Tell a Quieter Story

The put/call ratio came out of earnings at 0.457, 2.9 standard deviations above its 20-day mean of 0.417. That is the same elevated reading reported earlier today. It reflects hedging activity post-print, not a fresh escalation.

On the borrow side, conditions have eased further. Cost to borrow fell 52% over the past week to 0.24%. Availability is effectively uncapped, with over 135 million shares available to lend against fewer than 6 million currently borrowed. There is no pressure in the lending market from either direction.

Short interest sits at 4.25% of the free float, down 15.9% over the past month.

Data Summary

  • JP Morgan upgrades to Overweight, target $35 (from $34), implying 43% upside to current price
  • Wells Fargo maintained Overweight, cut target to $33 from $38
  • Consensus mean target: $30.04 vs current price of $24.43
  • Put/call ratio: 0.457, a z-score of 2.9 above its 20-day mean
  • Cost to borrow: 0.24%, down 52% on the week
  • Short interest: 4.25% of free float, down 15.9% over the past month
  • Retail attention z-score: 3.67 above 90-day average as of October 28

The next scheduled earnings date is February 17, 2027. How the desk reacts to JP Morgan's upgrade over the coming sessions is the clearest signal to watch.

Stocks in this article

See the live data behind this article on ORTEX.

Open CSTM on ORTEX →

How this article was generated

Generated
29 Oct 2026, 20:47
Data as of
29 Oct 2026, 20:41
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.